Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Nathan, David
Item TypeName
Academic Article Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging.
Academic Article Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
Academic Article Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
Academic Article Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.
Academic Article Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study.
Academic Article Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
Academic Article The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
Academic Article Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
Concept Glucose Intolerance
Academic Article The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
Academic Article Impaired fasting glucose and impaired glucose tolerance: implications for care.
Academic Article Navigating the choices for diabetes prevention.
Academic Article Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
Search Criteria
  • Glucose Intolerance
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.